Review





Similar Products

99
ATCC human tumorigenic prostate cancer cell line vcap
Human Tumorigenic Prostate Cancer Cell Line Vcap, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human tumorigenic prostate cancer cell line vcap/product/ATCC
Average 99 stars, based on 1 article reviews
human tumorigenic prostate cancer cell line vcap - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
ATCC vcap human prostate cancer cell lines
Vcap Human Prostate Cancer Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vcap human prostate cancer cell lines/product/ATCC
Average 99 stars, based on 1 article reviews
vcap human prostate cancer cell lines - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
ATCC human prostate cancer cell lines vcap
Human Prostate Cancer Cell Lines Vcap, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human prostate cancer cell lines vcap/product/ATCC
Average 99 stars, based on 1 article reviews
human prostate cancer cell lines vcap - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
ATCC crl 2876 human prostate cancer cell line pc3 atcc crl 1435
Crl 2876 Human Prostate Cancer Cell Line Pc3 Atcc Crl 1435, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/crl 2876 human prostate cancer cell line pc3 atcc crl 1435/product/ATCC
Average 99 stars, based on 1 article reviews
crl 2876 human prostate cancer cell line pc3 atcc crl 1435 - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
ATCC human prostate cancer cell line vcap
Antiandrogenic effect of PFASs on the expression of (A) PSA , (B) FKBP5, and (C) AR in <t>VCaP</t> <t>human</t> <t>prostate</t> cancer cells. Cells were cotreated with 625 pM testosterone and PFASs or 50 nM OHF (positive control) for 24 h under hormone deprived conditions (10% CD FBS). Values are expressed as the mean fold change ± S.E.M. from three independent experiments. Statistical analysis was performed using one-way ANOVA followed by a multiple comparison analysis with Dunnett’s test to compare the difference in fold change between exposed groups and the corresponding control (625 pM testosterone). Significance levels are represented with asterisk as following: *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. The P trend is determined based on linear regression analysis.
Human Prostate Cancer Cell Line Vcap, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human prostate cancer cell line vcap/product/ATCC
Average 99 stars, based on 1 article reviews
human prostate cancer cell line vcap - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

90
Johns Hopkins HealthCare human vertebral-cancer of the prostate (vcap) cell line
Antiandrogenic effect of PFASs on the expression of (A) PSA , (B) FKBP5, and (C) AR in <t>VCaP</t> <t>human</t> <t>prostate</t> cancer cells. Cells were cotreated with 625 pM testosterone and PFASs or 50 nM OHF (positive control) for 24 h under hormone deprived conditions (10% CD FBS). Values are expressed as the mean fold change ± S.E.M. from three independent experiments. Statistical analysis was performed using one-way ANOVA followed by a multiple comparison analysis with Dunnett’s test to compare the difference in fold change between exposed groups and the corresponding control (625 pM testosterone). Significance levels are represented with asterisk as following: *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. The P trend is determined based on linear regression analysis.
Human Vertebral Cancer Of The Prostate (Vcap) Cell Line, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human vertebral-cancer of the prostate (vcap) cell line/product/Johns Hopkins HealthCare
Average 90 stars, based on 1 article reviews
human vertebral-cancer of the prostate (vcap) cell line - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

99
ATCC metastatic human prostate cancer vcap cell lines
Antiandrogenic effect of PFASs on the expression of (A) PSA , (B) FKBP5, and (C) AR in <t>VCaP</t> <t>human</t> <t>prostate</t> cancer cells. Cells were cotreated with 625 pM testosterone and PFASs or 50 nM OHF (positive control) for 24 h under hormone deprived conditions (10% CD FBS). Values are expressed as the mean fold change ± S.E.M. from three independent experiments. Statistical analysis was performed using one-way ANOVA followed by a multiple comparison analysis with Dunnett’s test to compare the difference in fold change between exposed groups and the corresponding control (625 pM testosterone). Significance levels are represented with asterisk as following: *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. The P trend is determined based on linear regression analysis.
Metastatic Human Prostate Cancer Vcap Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/metastatic human prostate cancer vcap cell lines/product/ATCC
Average 99 stars, based on 1 article reviews
metastatic human prostate cancer vcap cell lines - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

Image Search Results


Antiandrogenic effect of PFASs on the expression of (A) PSA , (B) FKBP5, and (C) AR in VCaP human prostate cancer cells. Cells were cotreated with 625 pM testosterone and PFASs or 50 nM OHF (positive control) for 24 h under hormone deprived conditions (10% CD FBS). Values are expressed as the mean fold change ± S.E.M. from three independent experiments. Statistical analysis was performed using one-way ANOVA followed by a multiple comparison analysis with Dunnett’s test to compare the difference in fold change between exposed groups and the corresponding control (625 pM testosterone). Significance levels are represented with asterisk as following: *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. The P trend is determined based on linear regression analysis.

Journal: Journal of hazardous materials

Article Title: In Vitro characterization of the endocrine disrupting effects of per- and poly-fluoroalkyl substances (PFASs) on the human androgen receptor

doi: 10.1016/j.jhazmat.2022.128243

Figure Lengend Snippet: Antiandrogenic effect of PFASs on the expression of (A) PSA , (B) FKBP5, and (C) AR in VCaP human prostate cancer cells. Cells were cotreated with 625 pM testosterone and PFASs or 50 nM OHF (positive control) for 24 h under hormone deprived conditions (10% CD FBS). Values are expressed as the mean fold change ± S.E.M. from three independent experiments. Statistical analysis was performed using one-way ANOVA followed by a multiple comparison analysis with Dunnett’s test to compare the difference in fold change between exposed groups and the corresponding control (625 pM testosterone). Significance levels are represented with asterisk as following: *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. The P trend is determined based on linear regression analysis.

Article Snippet: The human prostate cancer cell line (VCaP) which expresses high levels of wild-type AR, was purchased from ATCC.

Techniques: Expressing, Positive Control, Comparison, Control

Antiandrogenic effect of PFASs on the AR protein levels in prostate cancer cells (VCaP). (A and B) cells were cotreated with 625 pM testosterone (T) and PFASs or 50 nM OHF (positive control) for 24 h under hormone deprived conditions (10% CD FBS). (C and D) cells were treated with PFASs or 1 μM enzalutamide (Enz, positive control) for 48 h under normal conditions (containing 10% intact, non-CD stripped FBS). AR proteins were detected using AR-specific antibody and α-tubulin was used as a loading control. Values are expressed as the mean fold change ± S.E.M. from three independent experiments. Statistical analysis was performed using one-way ANOVA followed by a multiple comparison analysis with Dunnett’s test to compare the difference in fold change between exposed groups and the corresponding control (625 pM testosterone for panel B) and (0.1% v/v DMSO for panel D). Significance levels are represented with asterisk as following: *p < 0.05 and * **p < 0.001.

Journal: Journal of hazardous materials

Article Title: In Vitro characterization of the endocrine disrupting effects of per- and poly-fluoroalkyl substances (PFASs) on the human androgen receptor

doi: 10.1016/j.jhazmat.2022.128243

Figure Lengend Snippet: Antiandrogenic effect of PFASs on the AR protein levels in prostate cancer cells (VCaP). (A and B) cells were cotreated with 625 pM testosterone (T) and PFASs or 50 nM OHF (positive control) for 24 h under hormone deprived conditions (10% CD FBS). (C and D) cells were treated with PFASs or 1 μM enzalutamide (Enz, positive control) for 48 h under normal conditions (containing 10% intact, non-CD stripped FBS). AR proteins were detected using AR-specific antibody and α-tubulin was used as a loading control. Values are expressed as the mean fold change ± S.E.M. from three independent experiments. Statistical analysis was performed using one-way ANOVA followed by a multiple comparison analysis with Dunnett’s test to compare the difference in fold change between exposed groups and the corresponding control (625 pM testosterone for panel B) and (0.1% v/v DMSO for panel D). Significance levels are represented with asterisk as following: *p < 0.05 and * **p < 0.001.

Article Snippet: The human prostate cancer cell line (VCaP) which expresses high levels of wild-type AR, was purchased from ATCC.

Techniques: Positive Control, Control, Comparison